DNDieudonné Mumba Ngoyi

Dieudonné Mumba Ngoyi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dieudonné Mumba Ngoyi has a total of 400 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantitative facial phenotyping and age-associated differences in Sickle cell disease using interpretable machine learning

    by D’ANdre Spencer, Xinyang Liu, Kizito Mosema-Be-Amoti, Gisèle Kandosi, Matthew S. Bramble, Faisal Al Munajjed, Esther Likuba, Daniel Okitundu Luwa E-Andjafono, Laure Tshibambe, Brian Colwell, et al.

    Sickle cell disease (SCD) is a common inherited genetic disorder and contributor to global childhood mortality and morbidity, particularly in Sub-Saharan Africa. Craniofacial and skeletal changes have been described in SCD, but the subtle soft-tissue facial patterns and their variation have not been quantitatively characterized using machine-learning methods. We analyzed 308 front-facing smartphone photographs from 154 participants with electrophoresis-confirmed SCD and 154 age- and sex-matched controls aged from 5 months to 19 years recruited in Kinshasa, Democratic Republic of the Congo. Predefined geometric and texture-based facial descriptors were extracted from standardized images using manually annotated landmarks. An interpretable linear support vector machine with recursive feature elimination was evaluated using leave-one-out cross-validation, with features ranked according to their relevance for distinguishing participants with SCD from controls. Cross-sectional age- and sex- stratified analyses evaluated variation in selected features The facial analysis algorithm identified eight geometric and six texture discriminative features that were significantly different between the cohorts. A combination of six geometric features contributed most consistently to internal discrimination: distance between medial and lateral canthi, angle at nasal ala, distance from nasion to philtrum, distance from medial canthi to the columella, distance from columella to the lower lip, and distance between nasal alae. The model achieved an AUROC of 0.843 [95% CI: 0.798,0.887], and an accuracy of 0.795 [95% CI: 0.750,0.840]. Between-group difference was limited in the youngest age groups and were more pronounced in several older age groups. These findings demonstrate preliminary evidence that SCD is associated with quantifiable morphometric patterns. External, longitudinal, and clinically characterized studies are needed to determine whether these features may serve as reproducible digital biomarkers within a broader supportive disease-assessment framework.

  • Open Access

    High Schistosomiasis Prevalence in Urban and Rural Primary School Children from Kimpese Health District, Democratic Republic of the Congo

    by Kevin Lubula Karume, Harry Noyes, Oscar Nyangiri, Julius Mulindwa, Olivier Fataki, Oscar Kwabanzawoko, Ronald Futila Kyong Shin, Jacent Nassuuna, Allison Elliott, Miriam Casacuberta-Partal, et al.

    Background: Schistosomiasis is a parasitic disease caused by flatworms known as schistosomes. The infection cycle starts when people shed eggs through the stool or the urine. Larva infects freshwater snails to later infect humans through the skin during water based activities. Schistosomiasis is commonly associated with rural areas. In this study, we wanted to see if the schistosomiasis distribution is different in rural and urban areas, along with potential risk factors associated with schistosomiasis distribution. Methodology: Fresh urine samples were collected from 1,699 school-aged children (5 – 15 years old) in urban and rural sites in the Kimpese health district. Prevalence of haematobium and mansoni schistosomiasis was determined using, respectively, the urine sedimentation and the Point-of-Care Circulating Cathodic Antigen test with a quantitative estimate of infection intensity obtained with an RDT-Reader. Collected risk factors were tested for association with schistosomiasis infection and its intensity. Results: The overall prevalence of schistosomiasis found in urban and rural areas was 75% and 82% respectively, with higher prevalence of S. mansoni in rural schools, and higher S. haematobium prevalence in urban schools. The difference in total prevalence between schools in urban and rural areas was significant, X 2 (1, N = 1699) = 13.03, p = .0003. S. mansoni intensity of infection was also higher in rural children (mean = 162 mV) compared to those in urban areas (mean = 76 mV) (p < 2e-16). Male gender, washing dishes in the river, and swimming were associated with schistosomiasis in urban areas. Age, Springs, and rivers were significant factors in rural sites. Age, river, and washing dishes in the river were factors associated with the intensity of infection. Conclusion: Our results showed very high prevalence in both rural and urban areas, which implies that control programs should consider them with the same interest and also revise control strategies. Author Summary: Schistosomiasis is a common but often overlooked parasitic disease that affects millions of people around the world. More than 290 million people are at risk of becoming infected. The disease is mainly spread when people come into contact with freshwater sources, such as rivers and streams, that contain infected snails carrying the parasite. In this study, we tested 1,699 schoolchildren aged 5 to 15 years living in both urban and rural communities of the Kimpese district in Kongo Central Province, Democratic Republic of the Congo. Using a rapid diagnostic test (POC-CCA), we found that schistosomiasis was very common in both settings, affecting about 75% of children in urban areas and 82% in rural areas. Intestinal schistosomiasis was more common in rural communities, while urinary schistosomiasis was found more frequently in urban communities. Factors such as being male, age, and activities involving river water, especially swimming and washing dishes, were linked to a higher risk of infection. These findings show that schistosomiasis is not only a rural health problem. Even in urban areas where access to safer water may be better, people remain at risk if they continue to have regular contact with rivers and other freshwater sources that contain the parasite.

  • Open Access

    Age-dependent Diagnostic Relevance of Clinical Features Among Suspected Mpox Cases in a Clade La-endemic Setting in the Democratic Republic of the Congo: Prospective Cohort Study

    by Ryoko Asari, Sarah Mukutsha Sango, Mika Kumagai, Ruth Diavita, Jacques Likofata, Yoshiyuki Wakabayashi, Natsuko Kaku, Yu Nakagama, Jean-Jacques Muyembe, Dieudonné Mumba Ngoyi, et al.

    Background: When laboratory testing is constrained, suspected-case definitions guide mpox triage, isolation, contact tracing, and surveillance. In clade Ia-endemic settings, children and adults may differ in exposure context, clinical presentation, and the diagnostic value of syndromic features. Methods: We prospectively enrolled patients meeting the national case definition of suspected mpox in Équateur province, Democratic Republic of the Congo. We collected standardized epidemiological and clinical data. Multivariable logistic regression analyses adjusted for age, sex, and residence were used to assess associations, age-by-feature interactions, and age-specific likelihood ratios. Findings: Of 151 suspected cases, 90 (60%) were PCR-positive; all cases were classified as clade Ia MPXV. PCR-positive participants were older than PCR-negative participants (median, 24·5 years [IQR,15·0 – 32·0 years] vs 9·00 years [IQR, 2·00 –20·0 years]), and positivity increased with age. Contact with a suspected case was strongly associated with PCR-confirmed mpox (adjusted OR, 13·8; 95% CI, 4·02–58·5), whereas wild animal contact appeared more relevant in younger patients. Contact history and genital or inguinal manifestations became more informative diagnostically with age; ocular, musculoskeletal, and palmoplantar features were relatively more informative in younger patients. Interpretation: The diagnostic relevance of epidemiological and clinical features varied substantially across age groups. In this clade Ia-endemic setting, age-informed interpretation of suspected mpox cases may improve triage, prioritisation of laboratory testing, and surveillance where diagnostic resources are limited.

  • Open Access

    Deciphering the etiology of the 2024 outbreak of undiagnosed febrile illness in Panzi, Democratic Republic of the Congo

    by Tony Wawina-Bokalanga, Jean-Claude Makangara-Cigolo, Rilia Ola-Mpumbe, Emmanuel Lokilo, François Mwakisenda-Tshakotsho, Mbonga Delphine, Immaculée Kahindo, Alphonse Tshonaka-Nkololo, Emmanuel Hasivirwe Vakaniaki, Nicholas Loman, et al.

    In late 2024, an outbreak of over 400 cases of undiagnosed febrile illness, predominantly presenting as fever and cough, was reported in Panzi Health Zone, southwestern Democratic Republic of the Congo. Here we conducted an epidemiological and laboratory investigation to determine the etiology of the outbreak. Clinical data and specimens were prospectively collected from 108 individuals, of whom 59/108 (54.6%) were female. Children aged Plasmodium falciparum was detected in 56/108 (51.8%) individuals. Co-infections were also detected, with influenza A(H1N1)pdm09 virus in 16/56 (28.6%) and severe acute respiratory syndrome coronavirus 2 in 10/56 (17.9%) individuals. No novel pathogens were detected via metagenomics. Our findings suggest that the outbreak was primarily associated with a surge in malaria cases, with concurrent viral respiratory infections. Increasing decentralized laboratory capacity and strengthening broader health systems remain crucial for faster outbreak detection and investigation.


  • Open Access

    The STROGHAT study protocol: An intervention study to evaluate safety, effectiveness and feasibility of treating gambiense HAT seropositive subjects with acoziborole.

    by Elena Nicco, Veerle Lejon, Erick Mwamba Miaka, Dieudonné Mumba, Alain Mpanya, Charles Kambo, Digas Ngolo, Wilfried Mutombo, Stéphane Hugonnet, Sandra Rembry, et al.

    Background Coordinated efforts in the control of gambiense human African trypanosomiasis (gHAT) have significantly reduced its endemicity. WHO targets interruption of transmission by 2030. However, challenges remain, including low sensitivity of the current parasitological confirmation tests, leaving a potential human reservoir untreated. Acoziborole, a single-dose oral treatment, effective in both disease stages with a good safety profile, offers the potential of treatment of parasitologically negative gHAT seropositive subjects, which could improve diagnostic sensitivity. The STROGHAT study aims to evaluate whether this approach can lead to elimination of T.b. gambiense from its human reservoir, and to provide further safety data on acoziborole. It also includes a costing analysis and a prospective evaluation of the performance of the screening and diagnostic tests used. Methods STROGHAT is a one-arm epidemiological study, with a nested phase IIIb, one-arm, open label, non-randomized, multicentre clinical trial. It will be implemented over four years in the endemic region of the Equateur North, in the Democratic Republic of Congo. For the first three years, parasitologically negative gHAT seropositive subjects will be treated with acoziborole, while parasitologically confirmed cases will receive standard of care. Individual follow-up needs and accurate prevalence estimate will be based on immunological and molecular tests performed for all gHAT screening test seropositive subjects at a reference laboratory. In the fourth year, standard procedures will resume, and a prevalence survey will assess whether interruption of transmission has been achieved. Discussion The manuscript outlines the study background, objectives and methods while discussing its strengths and challenges. If successful, the STROGHAT study will provide critical evidence on the effectiveness, safety and feasibility of the new strategy, and inform future elimination strategies. Clinical trial registration NCT06356974. Date of registration: April 4, 2024.


  • Open Access

    G1 and G2 variants of apolipoprotein L1 among Central African population in Trypanosoma brucei gambiense endemic rural area

    by Dominique M Mupepe, Marie-Noelle Nl Wameso, Hippolyte N Situakibanza, Pépé M Ekulu, Jean Robert R Makulo, Jean Marie N Kayembe, Agathe B Nkoy, Raggue Zm Mvibudulu, Lambertus P Van Den Heuvel, Elena N Levtchenko, et al.

    Introduction: Apolipoprotein L1 (APOL1) risk variants (G1, G2) are known to enhance the protective ability against human African trypanosomiasis (HAT), in addition to their role in kidney and cardiovascular disease. The effects of these variants on trypanosome infection could differ regionally owing to local adaptations of the host and pathogen. This study explored APOL1 risk variants distribution in HAT-infected and non-infected populations from a rural Trypanosoma brucei gambiense (T. b. gambiense) endemic area in Central Africa. Methodology: We conducted a cross-sectional study with 124 participants in Masimanimba, a HAT-endemic region in the Democratic Republic of the Congo (DRC). Student’s and Pearson`s Chi-square test or Fisher’s exact tests were used as appropriate. Statistical significance was set at p < 0.05, based on two-tailed test. Results: 71 participants (57%) were infected by Trypanosoma, 65 (52%) of whom were symptomatic and 6 (5%) asymptomatic. The overall frequency of risk alleles was 16.5% for G1 and 8.8% for G2. Neither variant was associated with the susceptibility to T. b. gambiense infection (for G1: 19.7% vs. 26.4 %; OR: 0.68 [95% CI: 0.29–1.62], p = 0.394; for G2: 11.3% vs. 13.2% 0.83 [0.27–2.58], p = 0.786). All of the G2 variants were found in symptomatic patients Conclusions: APOL1 variants are common in populations living in T. b. gambiense endemic areas of the DRC. Neither variant was associated with susceptibility to T. b. gambiense. The G2 variant was the only one associated with symptomatic HAT.


  • Open Access

    Glutathione peroxidase 3 is a potential biomarker for konzo

    by Matthew S. Bramble, Victor Fourcassié, Neerja Vashist, Florence Roux-Dalvai, Yun Zhou, Guy Bumoko, Michel Lupamba Kasendue, D’aNdre Spencer, Hilaire Musasa Hanshi-Hatuhu, Vincent Kambale-Mastaki, et al.

    Konzo is a neglected paralytic neurological disease associated with food (cassava) poisoning that affects the world’s poorest children and women of childbearing ages across regions of sub-Saharan Africa. Despite understanding the dietary factors that lead to konzo, the molecular markers and mechanisms that trigger this disease remain unknown. To identify potential protein biomarkers associated with a disease status, plasma was collected from two independent Congolese cohorts, a discovery cohort (n = 60) and validation cohort (n = 204), sampled 10 years apart and subjected to multiple high-throughput assays. We identified that Glutathione Peroxidase 3 (GPx3), a critical plasma-based antioxidant enzyme, was the sole protein examined that was both significantly and differentially abundant between affected and non-affected participants in both cohorts, with large reductions observed in those affected with konzo. Our findings raise the notion that reductions in key antioxidant mechanisms may be the biological risk factor for the development of konzo, particularly those mediated through pathways involving the glutathione peroxidase family.


  • Open Access

    Publisher Correction: IL-17 signalling is critical for controlling subcutaneous adipose tissue dynamics and parasite burden during chronic murine Trypanosoma brucei infection

    by Matthew C. Sinton, Praveena R. G. Chandrasegaran, Paul Capewell, Anneli Cooper, Alex Girard, John Ogunsola, Georgia Perona-Wright, Dieudonné M Ngoyi, Nono Kuispond, Bruno Bucheton, et al.


  • Open Access

    Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo

    by Gauthier Mesia Kahunu, Sarah Wellmann Thomsen, Louise Wellmann Thomsen, Hypolite Muhindo Mavoko, Patrick Mitashi Mulopo, Emma Filtenborg Hocke, Papy Mandoko Nkoli, Vito Baraka, Daniel T.R. Minja, Andria Mousa, et al.


  • Open Access

    IL-17 signalling is critical for controlling subcutaneous adipose tissue dynamics and parasite burden during chronic murine Trypanosoma brucei infection

    by Matthew C. Sinton, Praveena R. G. Chandrasegaran, Paul Capewell, Anneli Cooper, Alex Girard, John Ogunsola, Georgia Perona-Wright, Dieudonné M Ngoyi, Nono Kuispond, Bruno Bucheton, et al.

    In the skin, Trypanosoma brucei colonises the subcutaneous white adipose tissue, and is proposed to be competent for forward transmission. The interaction between parasites, adipose tissue, and the local immune system is likely to drive the adipose tissue wasting and weight loss observed in cattle and humans infected with T. brucei. However, mechanistically, events leading to subcutaneous white adipose tissue wasting are not fully understood. Here, using several complementary approaches, including mass cytometry by time of flight, bulk and single cell transcriptomics, and in vivo genetic models, we show that T. brucei infection drives local expansion of several IL-17A-producing cells in the murine WAT, including TH17 and Vγ6+ cells. We also show that global IL-17 deficiency, or deletion of the adipocyte IL-17 receptor protect from infection-induced WAT wasting and weight loss. Unexpectedly, we find that abrogation of adipocyte IL-17 signalling results in a significant accumulation of Dpp4+Pi16+ interstitial preadipocytes and increased extravascular parasites in the WAT, highlighting a critical role for IL-17 signalling in controlling preadipocyte fate, subcutaneous WAT dynamics, and local parasite burden. Taken together, our study highlights the central role of adipocyte IL-17 signalling in controlling WAT responses to infection, suggesting that adipocytes are critical coordinators of tissue dynamics and immune responses to T. brucei infection.